What is a Growth Potential of the Particle Therapy Market?
According to a research report “Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027″ published by MarketsandMarkets, the particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027.
In this report, the particle therapy market is segmented on the basis of type, products and services, cancer type, systems, and region.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137
“Pediatric cancer defined for the largest share in the particle therapy market by cancer type”
Based on cancer type, the particle therapy market is segmented into prostate cancer. pediatric cancer, lung cancer, breast cancer, head & neck cancer, and other cancers. The pediatric cancer segment is holds the largest share of 24.8% of the particle therapy market in 2021 with CAGR of 10.4% during the forecast period.
“Products such as cyclotron accounted for the largest share in the particle therapy market by product type”
Based on products & services, the particle therapy market is segmented into products and services. In 2021, products are estimated to account for the largest share of 78.6% of the particle therapy market. The increasing incidence of cancer cases is the major factor responsible for the growth of this segment.
“Based on system, multi-room systems holds the largest share in the particle therapy”
Based on the system, the particle therapy market is segmented into single-room and multi-room particle therapy systems. The multi-room systems segment is expected to account for the largest share (67.8%) of the particle therapy market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=12809137
Key Market Players:
Prominent players in the particle therapy market include IBA Worldwide (EU), Mevion Medical Systems (US), Varian Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Hitachi, Ltd. (Japan), Toshiba Medical Systems Corporation (Japan), and Provision Healthcare, LLC (US). These players have implemented various development strategies such as product launches, acquisition, and expansion to other geography.
The research report categorizes particle therapy market into the following segments and sub-segments:
By Type
- Proton Therapy
- Heavy Ion Therapy
By Product & Service
- Products
- Services
By System
- Multi-Room Systems
- Single-Room Systems
By Cancer Type
- Pediatric Cancer
- Prostate Cancer
- Lung Cancer
- Breast Cancer
- Head and Neck Cancer
- Other Cancers
By Application
- By App Treatment Applications
- Research Applications
By Region
- North America
- Europe
- Asia pacific
- Latin america
- Middle east & africa
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=12809137
Don’t miss out on business opportunities in Particle Therapy Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
